FOLD - Amicus Therapeutics files to sell 2.5M shares for holders
2023-11-08 18:02:41 ET
More on Amicus Therapeutics
- Amicus Therapeutics Q3 2023 Earnings Call Transcript
- Amicus Therapeutics: The Right Play Now
- Amicus Therapeutics: Limited Label For Pombiliti And Opfolda And Why It May Not Matter
- Amicus Therapeutics beats Q3 top and bottom line estimates; raises FY23 Galafold revenue outlook
- Amicus Therapeutics Q3 2023 Earnings Preview
For further details see:
Amicus Therapeutics files to sell 2.5M shares for holders